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Purpose: Alzheimer disease (AD) is a progressive neurodegenerative disorder that is
caused by neuroinflammation and oxidative stress. The present study aimed to
characterize and then investigate the memory-enhancing potential of Viola odorata
methanolic extract in lipopolysaccharide (LPS)–treated mice.
Methods: V. odorata characterization was done by using the GCMS technique.
Neuroinflammation was induced by the intracerebroventricular administration of LPS at
a dose of 12 µg. Animals were divided randomly into six groups (n  10). Group I was
normal control, which was given vehicle. Group II was disease control, which received LPS
(12 µg) via the intracerebroventricular route. Group III was standard, which was
administered with donepezil (3 µg) orally for 21 days. Groups IV–VI were the treatment
groups, which were administered with the extract at 100, 200, and 400mg/kg dose levels
orally respectively for 21 days. Groups III–VI received LPS (12 µg) on the first day along with
their treatments. During the treatment, the animals were assessed for memory retention by
employing different behavioral paradigms namely elevated plus maze, passive avoidance,
foot shock and open field. Various mediators [endogenous antioxidants,
neurotransmitters, and acetylcholinesterase (AChE)] involved in the pathogenesis of AD
were quantified by using the UV spectrophotometric method.
Results: Extract-treated groups showed a remarkable improvement in cognitive
impairment in all behavioral paradigms. Oxidative stress biomarkers, that is, superoxide
dismutase, catalase, and glutathione were raised dose-dependently in the treatment
groups with a dose-dependent decrease in the malonaldehyde and AChE levels in the
brains of the treated animals. The treatment groups showed decreased levels of
inflammatory biomarkers, that is, tumor necrosis factor–alpha, nuclear factor kappa
light-chain enhancer of activated β-cells, and cyclo-oxygenase, which supports the
therapeutic effectiveness of the treatment.
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Conclusion: Based on behavioral, oxidative stress biomarker, and neuroinflammatory
data, it is concluded that V. odorata possesses memory-enhancing activity and may prove
a beneficial role in the management of AD.
Keywords: Viola odorata, memory-enhancing activity, oxidative stress, lipopolysaccharide, cyclooxygenase-2,
tumor necrosis factor–alpha
INTRODUCTION
Alzheimer’s disease (AD) is a progressive neurodegenerative
disorder that commonly affects people older than 60 years
(Wu et al., 2018). The Lancet communication report on
dementia reported that the risk factor for the
neuropathological development of dementia is less in early life
(<45 years) and increases gradually frommid life (45–65 years) to
later life (>65 years). The key indicative biomarkers of AD are
amyloid beta (Aβ) and tau proteins. According to the Lancet
communication report on AD, these biomarkers never develop in
people who have normal cognitive functions (Livingston et al.,
2020).
Neuroinflammation, mitochondrial dysfunction, protein
misfolding, oxidative stress, genetic disturbance, and
aggregation of misleading proteins are the causes of
neurodegenerative diseases (Kamil et al., 2019). AD is a
devastating disorder that slowly causes degeneration of
neurons and impairs cognitive abilities. The brain loses its
cell-to-cell connection (Wenk, 2003). The effect of AD on
memory capacity is not equal. Initially, short-term memory is
affected followed by episodic memory. At the start, there is
difficulty to obtain new memories and remembering observed
facts. As the disease advances, confusion, aggression, irritability,
mood swings, language breakdown, and long-term memory loss
may occur (Reitz et al., 2011). Certain regions of the subcortical
and cerebral cortex of the brain lose neurons and synapses in AD.
This results in the degeneration of the affected areas including the
cingulate gyrus, frontal cortex, parietal lobe, temporal lobe, and
hippocampus (Kumar and Singh, 2015). Although the cause of
AD is yet not clear, some promising reasons have been found. A
decrease in the synthesis or increased breakdown of acetylcholine
(ACh) neurotransmitter could be the cause of AD. The
serotonergic system imparts its effect on memory by
regulating the activity of ACh (Kandimalla and Reddy, 2017).
The other major theory states that two kinds of proteins, Aβ and
Tau proteins, run out of control in AD, which function actively in
the healthy brain (Wenk, 2003). Tau proteins nourish the brain
by supplying nutrients to the brain nerve cells. This damaged
protein entangles itself inside the nerve cell bodies and impedes
the nutrient supply to the cell. Hence, the transport system of
neurons collapses, which destroys the brain cells effectively (Lee
et al., 2005). Aβ protein is responsible for the brain’s normal
activity. Deposits or aggregates of Aβ protein are formed in the
initial stages of AD, which distorts the communication of neurons
by causing neuroinflammation. Aβ proteins are also responsible
for the ineffective concentration of dopamine and
norepinephrine, leading to cognitive dysfunction (Bitel et al.,
2012). Another significant neurodegenerative pathway for AD is
oxidative stress which results due to the overproduction of
reactive oxygen species (ROS) and gradual loss of antioxidants
defense mechanism. Antioxidant therapy has proven to
ameliorate cognitive impairments. Plants are the major source
of antioxidants; therefore, natural products can be a favorable
therapeutic approach for AD (Saxena et al., 2008).
Viola odorata Linn. (Sweet violet) is a perennial, short plant
that belongs to the family Violaceae that is commonly found in
open lands and road edges (Trusov, 2014). The herb is extensively
used in Unani and Ayurvedic medicines. Its flowers are edible and
consumed as a salad. V. odorata has been proved to have a variety
of biological activities (Colgrave et al., 2008) namely, anti-
inflammatory, antimicrobial, analgesic, anticancer, diuretic,
laxative, and antioxidant (Colgrave et al., 2008). Different
phytochemical constituents like cyclotides, steroids, flavonoids,
alkaloids, vitamins A and C, saponins, and tannins are found in
alcoholic and aqueous extracts of aerial parts of the plant
(Akhbari et al., 2012). The whole plant has been used as
febrifuge and used in infantile disorder, lung troubles, and
diaphoretic actions (Ahmad et al., 2009). V. odorata is
considered effective against various neurodegenerative diseases
such as AD, Parkinson’s disease, epilepsy, and anxiety owing to its
anti-inflammatory and antioxidant potential (Vishal et al., 2009).
Neuroinflammation can be induced by different chemicals,
but the neuroinflammation induction by the lipopolysaccharide
(LPS) is a popular method. LPS is a molecule present in the outer
membrane of gram-negative bacteria (Schumann et al., 1990).
Neuroinflammation is considered to play a significant role in the
pathology and clinical manifestations of AD due to the
overexpression of inflammatory agents in the affected regions
of the brain (Miklossy et al., 2006). LPS, an inflammation
activator, has been accounted for Aβ plaques and memory
impairment (Lee et al., 2008). LPS has been proved to cause
memory impairment by the stimulation of signaling pathway of
pro-inflammatory cytokines like tumor necrosis factor–alpha
(TNF-α level) and nuclear factor kappa B (NFK-β). The
current study aims to characterize and investigate the effect of
V. odorata on the cognitive functions of mice by employing the
behavior models and determining various biochemical markers.
MATERIALS AND METHODS
Plant Collection and Extraction
The plants containing aerial parts were collected from a local
nursery in Lahore, Pakistan. The plant samples were
authenticated by a botanist and were stored in the herbarium
of the Botany Department of the University of Punjab, Lahore,
Pakistan, under voucher number LAH#02720. V. odorata plant
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material was dried under shade for two weeks and then ground
electrically into a fine coarse powder. Powdered plant material
(1000 g) was extracted by using the maceration process with
methanol (3,400 ml), and 1400 ml water in the ratio of 2:1 for
7 days at room temperature. After a week, this mixture was
filtered, and then by using a rotary evaporator, solvent was
evaporated at 60°C under reduced pressure. It was dried in a
dried oven, and a dark brown thick paste was obtained. This
extract was weighed, and the percentage yield was determined by
using the formula given below. Then, it was stored in an airtight
jar in a refrigerator at 2–8°C for phytochemical and experimental
analysis.
Percentage Yield  Actual yield




The total flavonoid contents were determined by using the
method of Saleem et al. (2012) with little modifications. The
plant extract (0.2 ml) was mixed with 0.1 ml of 10% aluminum
nitrate (Al2NO3), 0.1 ml of 1 M potassium acetate, and 4.6 ml of
distilled water. This mixture was allowed to stand at room
temperature and was incubated for 50 min. Rutin was used as
standard. Absorbance was determined at 506 nm. A regression
line of rutin was used to calculate total flavonoid contents in the
sample plant extract (Saeed et al., 2012).
Total Phenol Contents
First, 0.5 ml of plant extract (100 µg/ml) was dissolved in 2 ml of
the Folin–Ciocalteu phenolic reagent, which was diluted in a ratio
of 1:10 with deionized water. This mixture was neutralized by
adding a 4 ml solution of sodium carbonate (7.5% w/v) and
incubated for 30 min. Absorbance was measured at 765 nm.
Gallic acid was used as a reference standard. The total
phenolic contents were measured by using the linear equation
of gallic acid (Ainsworth and Gillespie, 2007).
Gas Chromatography–Mass
Spectrophotometry (GC-MS) Analysis
GCMS analysis of phytochemical constituents of V. odorata was
performed by using an Agilent model 7890 B gas
chromatography (Agilent Technologies, CA, United States)
equipped with a DB-5MS (5% phenyl-polymethyl siloxane)
capillary column (3 mm × 0.25 mm, film thickness 0.25 µm)
interfaced to the Agilent 5997C mass-selective detector.
Initially, the temperature of the oven was held at 100°C for
1 min and then increased at a rate of 10°C/min up to 300°C.
Helium gas was used as carrier gas at a flow rate of 1 ml/min. The
temperature of the detector and injector was 280 and 250°C,
respectively. The mass spectrum was collected at 70 eV ionization
voltages over the range of 0–340 m/z. Electron multiplier voltage
was set at 1150 V. Percent relative peak was used to investigate the
quantity of all identified compounds. The identification of
compounds present in VOME was carried out by comparing
the known compounds available in the National Institute of
Standards and Technology (NIST) library databases (Jasim
et al., 2018).
Experimental Animals
The study was carried out on Swiss mice (male and female)
weighing 20–40 g. They were kept in the animal house of Riphah
International University, Lahore, Pakistan. The animal house was
maintained at standard conditions (12 h light and 12 h dark
cycles, 22 ± 3°C temperature and 45–55% humidity) with free
access to food and water. The animals were acclimatized to
standard conditions 5 days before the start of experimental
studies and were caged separately in groups of five per cage.
Ethical Approval
The experimental protocols were approved by the Ethical
Committee of Riphah Institute of Pharmaceutical Sciences,
Lahore, Pakistan, with the approval number of REC/RIPS-
LHR/039 and conducted according to the National Institutes
of Health (NIH) guidelines for care and use of laboratory animals.
Experimental Design
LPS (vial had 2000 µg which was dissolved in 2000 µl normal
saline; 1 µg/µl solution was prepared) solution was administered
via an intracerebroventricular (I.C.V.) route at a dose of 12 µg
(12 µl volume was administered) by using a stereotaxic apparatus
on the zeroth day of the study to all groups of animals, except the
control group (Wu et al., 2019). Animals were divided randomly
into six groups (n  10). Group I was normal control, which was
given vehicle (normal saline). Group II was disease control, which
received LPS (12 µg) via the I.C.V. route. Group III was standard,
which was administered with donepezil (3 µg) orally for 21 days.
Groups IV–VI were the treatment groups, which were
administered with extract at 100, 200, and 400 mg/kg dose
levels orally, respectively, for 21 days. All the doses were
prepared in normal saline.
All the animals were sacrificed at the end of the study under
isoflurane (3–5% isoflurane diluted with oxygen) anesthesia, and
the brains were excised from each mouse to perform biochemical
analysis on tissue homogenate.
Behavioral Tests
Morris Water Maze Test
The Morris water maze test (MWM) was used to evaluate spatial
learning and memory in experimental animals. It was performed
for five consecutive days (i.e., 8th to 12th days of the study) of
which training was conducted on the first four days, and the
probe test was performed on the 5th day (Wu et al., 2019). The
apparatus consisted of a circular pool with a diameter of 150 cm
and a height of 50 cm, which was filled with water up to 40 cm.
Water temperatures were maintained at 26 ± 1°C. The water maze
was divided into four quadrants, that is, east, west, north, and
south. A platform was placed at the center of any of the quadrants
in the water which was 2 cm above the water level during training
sessions, and was kept in the same position during training. The
mice were placed in the water facing the wall of the pool. The
starting point was changed on each training day (Niquet et al.,
2016). The animals were allowed to find the platform for 60 s.
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However, if an animal failed to find the platform within the
acquisition time, it was guided to the platform. This procedure
was repeated with each animal for the first four days of training.
On the fifth day, a probe test of 60 s was carried out in which
water was made opaque with nontoxic food color and the
platform was removed. Different parameters like escape
latency time (time taken to find the platform), time spent in
the platform quadrant, and the number of crossings in the
platform quadrant were recorded (Wu et al., 2019). Shorter
escape latency time is an indication of successful learning.
Elevated Plus Maze Test
The spatial memory of animals was evaluated by using the
elevated plus model (EPM) (Hope et al., 2019). It was
performed on the 14th and 15th days of the study. The 14th
day (day 1) was considered as a training day, whereas retention of
memory was examined on the 15th day (day 2) of the study. The
EPM apparatus was in plus shape with four arms (two open, 25 ×
5 cm and two closed (25 × 5 × 16 cm) with a central platform (5 ×
5). The apparatus was elevated 24 cm above the floor (Ari et al.,
2019). Transfer latency time (TL) (time taken by an animal to
enter from the open arm to any closed arm with all its four paws)
was observed by placing each animal at the end of the open arm
facing away from the central platform. Each mouse was freely
allowed to explore the apparatus for 90 s. If any animal failed to
enter into a covered arm within the assigned period (90 s), then it
was trained to enter the closed arm. A decrease in transfer latency
indicated cognitive improvement (Herbst et al., 2019).
Fear Conditioning Test
This test was performed to assess learning andmemory associated
with fear (Shoji et al., 2014). The test was performed on the 19th,
20th (training), and 21st (assessment) days of the study. The
apparatus comprised a square-shaped acrylic chamber having an
electric grid floor along with a shock generator and a sound
source. A light source was also attached to illuminate the
chamber. The sound speaker worked as an auditory cue as a
conditioned stimulus (CS), whereas the grids were connected
with a shock generator to provide a foot shock as an
unconditioned stimulus (US) (Shoji et al., 2014). Each treated
mouse was placed in the test apparatus to explore the chamber for
60 s. After this, a musical tone (2.8 kHz) was played as CS for 30 s,
and foot shock (0.7 mA) was given as the US on the last 2 s of the
tone. The procedure was repeated twice after every 60-s interval
(Angelo et al., 2003). On the assessment day, the treated mice
were evaluated for the retention of memory by repeating the same
procedure without applying foot shocks. Freezing time was
observed. Freezing is defined as a lack of movement, except
breathing (Ikegami et al., 2000).
Passive Avoidance Test
The passive avoidance model was used to evaluate the episodic
memory of animals (Kameyama et al., 1986). The test was
conducted in three sessions on the 21st (training) and 22nd
(assessment) days of the study. Step-down latency (SDL) was
measured in this test (Kameyama et al., 1986). The apparatus
consisted of a square wooden box (40 × 40 × 50 cm3) with an
electrifiable floor made up of stainless steel rods that were 1 cm
apart from each other. Three walls of the box were made up of
wood, whereas the fourth wall was made up of glass. A wooden
platform (8 × 5 × 1.5 cm) was placed at the center of the box. The
treated animal was delicately placed on the wooden stage, and
SDL (the time when an animal steps down the floor with all of its
four paws) was observed. When the animal stepped down from
the platform and placed all of its paws on the floor, electric shock
(0.4 mA) was applied for 3 s. The animals that step down within
2–15 s were chosen for the second session after 90 min of session
1 (Nasehi et al., 2010b). On the 22nd day, the mice that exhibited
the SDL less than 60 s were evaluated for memory retention in
session 3. Increased SDL indicated improvement in cognitive
function (Nasehi et al., 2010a).
Estimation of Oxidative Stress Biomarkers
Preparation of Tissue Homogenate
Animals were anesthetized by using isoflurane (Cartner et al.,
2007), and then, they were sacrificed by cervical dislocation to
excise their brain. Each separated brain was weighed and rinsed
with chilled normal saline. A tissue homogenate (10% w/v) was
prepared in 0.03M phosphate buffer (pH 7.4) with a ratio of 1:10.
The homogenate was centrifuged at 3,000 rpm for 15 min. The
supernatant layer was utilized to measure biochemical markers.
Estimation of Superoxide Dismutase (SOD)
Potassium phosphate buffer (0.1 M, pH 7.4) 2.8 ml and pyrogallol
solution 0.1 ml were added to 0.1 ml of brain homogenate. This
mixture was used to measure absorbance at 325 nm on a UV
spectrophotometer (Bhangale and Acharya, 2016).
Measurement of Catalase Activity (CAT)
The reaction mixture was prepared by the addition of 0.05 ml of
tissue homogenate, 1 ml of hydrogen peroxide (H2O2), and
1.95 ml of phosphate buffer (50 mM, pH 7). Absorbance was
recorded at 240 nm (Kim et al., 2016). Catalase activity was
determined by using the given formula:
Catalase activity  δOD
E × Vol of sample (ml) ×mg of protein,
where δOD  change in absorbance per minute and E 
extinction coefficient of hydrogen peroxide (0.071 mmol cm−1).
Protein contents were calculated by following Lowery et al.’s
(1951) method (Classics Lowry et al., 1951).
Measurement of Malondialdehyde (MDA)
One milliliter of brain homogenate was added to 3 ml of
thiobarbituric acid (TBA) reagent (which contained 5 N HCl
and trichloroacetic acid; TCA) to make a reaction mixture which
was heated for 15 min at 90°C. After cooling, it was centrifuged at
3,500 g for 10 min. The resultant pink-colored supernatant was
used to measure absorbance at 532 nm (Saxena et al., 2008).
The following equation was used to calculate the MDA level:
Conc.of MDA  Abs532 × 100 × Vt(1.56 × 105) ×WT × VU,
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where Abs532  absorbance, VT  total mixture volume, 1.56 ×
105 molar extinction coefficient, WT  weight of the brain, and
VU  aliquot volume.
Measurement of Reduced Glutathione (GSH) Level
Brain homogenate, 1 ml, was mixed with 1 ml of 10%
trichloroacetic acid, and it was centrifuged at 2000 g for
10 min. The resultant supernatant was separated in which 2 ml
of phosphate buffer (pH 8.4) and 0.5 ml of DTNB reagents were
added. The absorbance was measured at 412 nm (Saxena et al.,
2008).
The following equation was used to measure the GSH level:




Here, Y  absorbance at 412 nm, DF  dilution factor, BT  brain
tissue homogenate volume (1 ml), and VU  volume of
aliquot (1 ml).
Estimation of Acetylcholinesterase Activity
Tissue homogenate, 0.4 ml; 2.6 ml of phosphate buffer; and 100 µl
of DTNB were mixed thoroughly, and absorbance was measured
at 412 nm using a UV spectrophotometer. After stable reading, it
was recorded as basal reading. To this mixture, 20 µl
acetylthiocholine iodide was added as a substrate, and change
in absorbance was measured up to 10 min with an interval of
2 min (Talpate et al., 2014).
The average change in absorbance was calculated by using the
following formula, and the activity of acetylcholinesterase
(AChE) was expressed as µM/l/min/gm of tissue.
R  5.74(10−4) × ΔA
CO
.
Here, R  rate in moles substrate hydrolyzed per minute per gram
of tissue, ΔA  change in absorbance per minute, and Co 
original concentration of tissue, mg/ml.
Estimation of Neurotransmitters
Preparation of Aqueous Phase
The brain was mixed with 5 ml HCl–butanol. This mixture was
homogenized for 1 min and further centrifuged at 2000 rpm for
10 min. The resultant supernatant (1 ml) was separated in which
heptane 2.5 ml and 0.31 ml of HCl (0.1 M) were added. This
mixture was vigorously shaken and was again centrifuged under
the same conditions for the isolation of both phases. The upper
organic layer was discarded, and the lower aqueous phase was
used for the estimation of neurotransmitters, that is, serotonin,
dopamine, and noradrenaline (Rahman and Eswaraiah, 2008).
Estimation of Serotonin Level
O-phthaldialdehyde (OPT) 0.25 ml was added to 0.2 ml of the
aqueous phase. This mixture was then boiled up to 100°C for
almost 10 min. It was allowed to cool at room temperature.
Absorbance was measured at 440 nm. The blank solution was
HCl 0.25 ml without OPT (Hira et al., 2020).
Estimation of Dopamine and Noradrenaline Levels
HCl (0.4 M) 0.05 ml and EDTA (0.1 ml) were added to 0.2 ml of
aqueous phase, and then for oxidation process, 0.1 ml of iodine
solution (0.1 M in ethanol) was added to this mixture. Sodium
sulfite (Na2SO3) 0.1 ml was added to stop the oxidation process,
and after one and a half minute, acetic acid (0.1 ml) was added.
This reaction mixture was heated up to 100°C for about 6 min,
and it was allowed to cool at room temperature. Absorbance was
measured at 350 nm wavelength for dopamine, whereas at
450 nm, for noradrenaline. A blank solution was prepared by
reversing the order of addition of oxidation process reagents, that
is, first, Na2SO3 was added and then iodine (Ali et al., 2021).
Quantification of Inflammatory Biomarkers
NFK-β, TNF-α, and COX-2 With ELISA
The standard methods given in the ELISA kits were followed for
the quantification of inflammatory biomarkers NFK-β, TNF-α,
and COX-2. ELISA kits by Glory Science Co., Ltd were used for
NFK-β (catalog No. 10947) and COX-2 (catalog No. 11076), and
the Abcam ELISA kit was used for TNF-α (catalog No. ab46087).
Statistical Analysis
GraphPad Prism version 5.0 software was used for the statistical
evaluation of results. Data are expressed as mean ± SEM. One-
way ANOVA, followed by Dunnett’s multiple comparison test,
and two-way ANOVA, followed by the Bonferroni posttest, were




Flavonoids and phenolics compounds are the major natural
compounds that possess diverse activities. Flavonoid contents
were measured by using the following regression line equation:
y  0.1697x + 0.02231 (R2  0.9). Total flavonoid contents in the
methanolic extract of V. odorata were 2.407 mg of rutin
equivalent/g of sample.
Total Phenolic Contents
Phenolic contents were measured by using following regression
line equation; y  0.6360x + 0.09263 (R2  0.9). Total phenolic
contents in the methanolic extract of V. odorata were 1.224 mg of
gallic acid equivalent/gm of the sample.
Evaluation of In Vitro Antioxidant Activity by
Free Radical Scavenging DPPH Assay
The use of DPPH provides an easy and rapid way to evaluate
antioxidant activity. The maximum percentage scavenging
activity showed was at a concentration of 1 mg/ml, which was
the maximum concentration used. Thus, percentage activity
decreased with the reduction in the concentration of plant
extract (Figure 1).
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Liquid Chromatography–Mass
Spectrophotometry (GC-MS) Analysis
Methanolic extract of plant Viola odorata was analyzed by GC-
MS analysis, and various phytochemical constituents were
detected like eugenol, benzene acetaldehyde, tetradecanoic
acid, phytol, octadecatrenoic acid, undecane, gamma sitosterol,
and bacchotricum (Table 1; Figure 2).
Behavioral Studies
Effect of V. odorata Methanolic Extract on Learning
and Memory Using the Morris Water Maze Test
Spatial memory was assessed by observing the number of
crossings of animals in the target quadrant (north) by finding
the platform during the probe test. When LPS group was
compared with the control group, a significant decrease in the
number of crossing and time spent in the target quadrant were
observed, while escape latency was also significantly increased in
the LPS group. There is a significant (p < 0.001) decrease in the
escape latency (EL) in the treatment groups as compared to the
LPS group values on the training day and assessment day. If we
compared EL on the training day with the assessment day values,
then more decrease in EL was found on the assessment day
(Figure 3A). Data showed in Figures 3B,C that the number of
crossings and time spent in the target quadrant (north) were
increased in all the treated groups, except the LPS group animals.
Effect of V. odorata Methanolic Extract in Cognitive
Impairment Using the Elevated Plus Maze Test
The elevated plus maze test was performed on the 13th and 14th
days of the study to assess the cognitive performance of mice. A
significant rise in transfer latency (TL) was observed in the LPS
group as compared with the control group. The TL was
significantly (p < 0.001) decreased in a dose-dependent
manner in the treatment groups on the training day, whereas
on the assessment day, the treatment groups at 200 and
400 mg/kg experienced a significant (p < 0.001) decrease in TL
as compared to the LPS treated group value (Figure 4).
Effect of V. odorata Methanolic Extract on Fear
Learning and Memory Using the Fear Conditioning
Test
A fear conditioning test was performed on the 20th, 21st and
22nd days of study to assess the learning and memory of mice in
fear conditions. Freezing time was calculated, which indicated
the level of fear in mice. Percentage freezing response was
increased significantly (p < 0.001) at 200 and 400 mg/kg
VOME-treated groups with respect to the LPS group
(Figure 5).
Effects of V. odorata Methanolic Extract on Memory
Deficits Following the Passive Avoidance Test
A passive avoidance test was performed to investigate episodic or
long-term memory of mice by observing step-down latency
(SDL). On the assessment day, significant reduction in the
step-down latency was observed in the LPS group as
compared to the control group. Results in Figure 6 indicated
that SDL was increased significantly (p < 0.001) in the
treatment groups on the assessment day as compared to the
LPS group.
FIGURE 1 | Percentage scavenging activity of DPPH.
TABLE 1 | Phytochemical constituent analysis of Viola odorata methanolic extract by using the GC-MS analysis
Sr.no Retention time Compound name Molecular formula
1 3.60 Benzeneacetaldehyde C8H8O
2 8.476 Eugenol C10H12O2
3 11.721 2,5-Dihydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one C10H12O3
4 11.841 Tetradecanoic acid C14H28O2
5 12.616 3-Hydroxy-4,5-dimethoxybenzoic acid C9H10O5
6 14.328 Card-20 (22)-enolide, 3-[(2,6-dideoxy-4-O-. beta.-D-glucopyranosyl-3-O-methyl-. beta.-D-ribo-hexopyranosyl) oxy]-
5,14-dihydroxy-19-oxo
C36H54O14
7 13.373 Undecane, 3,8-dimethyl- C13H28
8 18.611 Octadecatrenoic acid C18H30O2
9 15.367 Phytol C20H40O
10 21.038 Acetic acid n-octadecyl ester C20H40O2
11 21.933 Di-isoctyl phthalate C24H38O4
12 21.831 Glycerol 1-palmitate C19H38O4
13 23.241 Bacchotricuneatin c C20H22O5
14 23.681 Gamma-sitosterol C29H50O
15 23.387 Octadecanoic acid C21H42O4
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Effects of V. odorata Methanolic Extract on
Oxidative Stress Biomarkers
The oxidative damage was evaluated through estimation of
biochemical marker (SOD, CAT, and GSH) levels in the brain
tissue. SOD, CAT, GSH, and protein levels were significantly (p <
0.05) increased, whereas MDA levels were decreased in the
treatment groups dose-dependently as compared to disease
group values. AChE activity was significantly decreased in the
treatment groups as compared to the disease group value
(Table 2). SOD and protein contents were quantified using
linear regression lines Y  0.0095x × 0.1939 and Y 
0.0000751x × 0.0000746, respectively.
Effect of V. odorata Methanolic Extract on
Neurotransmitters
Serotonin, noradrenaline, and dopamine levels were quantified in
the brain tissue using linear regression lines Y  0.03144x ×
01067; Y  0.1008x × 0.2508; and Y  0.2331x × 0.0164,
respectively. The level of serotonin was significantly decreased
in the brain of LPS treated animals; however, no difference was
observed in the levels of noradrenalin and dopamine. There was a
significant dose-dependent increase in the serotonin,
noradrenaline, and dopamine (Figures 7A–C).
Quantification of Inflammatory Biomarkers
NFK-β, TNF-α, and COX-2 With ELISA
Memory impairment is due to neurodegeneration and
inflammation that occurs in the brain. Inflammatory
biomarkers NFK-β, TNF-α, and COX-2 were raised in the LPS
disease group, whereas in the treatment groups, these
inflammatory biomarkers were significantly (p < 0.001)
decreased dose-dependently (Figures 8A–C), which is indicative
of therapeutic effectiveness of the treatment. Linear regression lines
y  0.0003 (X) + 0.1509 for TNF-α, y  0.0000829 (X) + 0.2934 for
NFK-β, and y  0.0003(x) + 0.1509 for COX-2 were used for the
quantification of the respective inflammatory biomarkers.
DISCUSSION
Various behavioral and biochemical studies were performed to
explore the anti-Alzheimer potential of VOME. In the present
study, phytochemicals like eugenol, gamma-sisterol, and phytol
were identified with GC-MS. These compounds possess several
pharmacological properties including anti-inflammatory and
antioxidant potentials (Duke, 1992; Govindharajalu, 2015;
Karthikeyan et al., 2017; Markkas and Barboza et al., 2018).
Neuroinflammation and oxidative stress which were induced
with LPS are causes of Alzheimer in the study (Pretorius et al.,
FIGURE 2 | GC-MS analysis of Viola odorata methanolic extract.
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2018). LPS causes significant memory impairment after I.C.V.
administration into the mice. Pro-inflammatory cytokines, that
is, TNF-α, IL-1β, and NFK-β, were produced in the glial cells
that initiate the cascade of inflammatory reactions with LPS.
These cytokines cause the deposition of amyloid proteins. LPS-
induced inflammation stimulates the apoptosis in the
mitochondria through increased levels of proapoptotic
proteins which is implicated in many neurodegenerative
diseases. Neuronal cell death following the LPS
administration may cause the activation of cyclooxygenase-2
(COX-2), which is a prominent factor involved in the
pathogenesis of cognitive dysfunction. COX-2 is the leading
cause of aggregation of amyloid beta precursor proteins
(APPs). LPS administration activates the COX-2 pathway
FIGURE 3 | Effect of V. odoratamethanolic extract on behavioral parameters of theMorris water maze test in mice. Histograms showing (A) escape latency, (B) No.
of crossings, and (C) time spent in quadrant. Data are expressed as mean ± SEM (n  10). *p < 0.05, **p < 0.01 and ***p < 0.001 as compared to the LPS treated group.
###p < 0.001 as compared to the control group.
FIGURE 4 | Histogram presenting effect of Viola odorata methanolic
extract on transfer latency (sec) in the elevated plus maze test in mice. Values
are expressed as mean ± SEM, n  10. ***p < 0.001 when compared with the
LPS-treated group. ###p < 0.001 as compared to the control group.
FIGURE 5 | Effect of Viola odorata methanolic extract on freezing time
(%) in the fear conditioning test in mice. Data are expressed as mean ± SEM,
n  10. ***p < 0.001, when compared with the LPS-treated group.
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under the influence of IL-1, leading to the production of
prostaglandins (PG), which strongly affect the functioning of
neurons involved in the memory (Griffin et al., 2013). LPS-
treated animals showed elevated levels of cycloxegenase-2
(COX-2) in a dose-dependent manner.
The treated animals were assessed for spatial learning, long-
term, and episodic memory by using Morris water maze,
elevated plus maze, passive avoidance, and fear conditioning,
respectively. Results of these models clearly indicated the
memory improvement in treated mice that had received LPS.
An aggravated inflammatory reaction could be the reason
for the increased production of ROS and nitric oxide (NO,
through NO synthase) that suggests that inflammation is
interlinked with oxidative stress. These ROS are responsible
for mitochondrial dysfunction causing reduced GSH levels,
which is the only antioxidant present in the mitochondria to
remove hydrogen peroxide (Hira et al., 2020). The oxidative
damage was evaluated through estimation of oxidative marker
(SOD, CAT, and GSH) levels in the brain tissue. SOD, CAT, and
GSH levels were significantly increased in VOME-treated groups
when compared with the animals that had received LPS.
The antioxidant property of the VOME might be due to the
presence of eugenol, gamma-sisterol, and phytol; the active
compounds that possessed the antioxidant property (Ogata et al.,
2000). The mitochondrial dysfunction may cause the decreased
utilization of ATP and acetyl Co-A, which affect the memory
impairment by impeding the cholinergic transmission (Hira et al.,
2019). Acetylcholinesterase enzyme causes the breakdown of
acetylcholine (ACh), which is the prominent factor to suppress
the production of inflammatory mediators (Tyagi et al., 2010). The
findings of the present study revealed the raised levels of AChE in
the LPS-treated animals that had suggested the excessive
inflammatory response. Donepezil, an FDA-approved drug, is
used in AD, which halts the breakdown of acetylcholine and
ultimately, increases the acetylcholine level and cholinergic
transmission at synapses. This might further confirm the
cognitive improvement due to increased concentration of ACh
(Wilkinson et al., 2004). The amyloid hypothesis suggests that
AChE is also responsible for the excessive deposition of APP
playing a crucial role in the pathogenesis of AD (Anand and
Singh, 2013). The memory-enhancing effect of the methanolic
extract ofV. odorata could be attributed to the presence of eugenol,
gamma-sisterol, and phytol in the plant under study.
Neurotransmitters (dopamine, serotonin, and noradrenaline)
levels are decreased in AD. Low levels of NA initially results in
anxiety and lack of attention, which later on progresses to AD.
Noradrenaline transmission is affected due to the degeneration in
noradrenergic neurons (Chalermpalanupap et al., 2013). Serotonin
is related to cognitive abilities by mediating cholinergic
transmission through acetylcholine. During the early stage of
AD, dwindled dopaminergic neuronal activity is also reported in
the progression of memory loss (Reinikainen et al., 1990). The
treatment groups challenged with LPS exhibited an increased
level of all neurotransmitters (dopamine, serotonin, and
noradrenaline) in comparison to the disease group.
CONCLUSION
The outcome of the present study proposes that the methanolic
extract of V. odoratamay be therapeutically effective in memory
improvement by increasing oxidative stress biomarkers and
neurotransmitters and decreasing pro-inflammatory markers.
However, the exact mechanism by which it ameliorates memory
functions is still unknown and needs further study at the
molecular level.
FIGURE 6 | Histogram presenting the effect of Viola odoratamethanolic
extract on the step-down latency (sec) in the passive avoidance test in mice.
Data are expressed as mean ± SEM, n  10. ***p < 0.001 as compared to the
LPS-treated group. ###p < 0.001 as compared to the control group.
TABLE 2 | Effects of Viola odorata methanolic extract on oxidative stress biomarkers and acetylcholinesterase
Treatment
groups


















Control 1 ml/kg 22.2 ± 0.3 15.06 ± 0.005 1.789 ± 0.005 19.30 ± 0.1 1.88 ± 0.004 0.48 ± 0.005
Disease (LPS) 12 µg 13.0 ± 0.05a 6.91 ± 0.01a 0.406 ± 0.005a 16.65 ± 0.05a 1.924 ± 0.001a 1.245 ± 0.05a
Standard
(donepezil)
3 µg 39.70 ± 0.25b 13.40 ± 0.005b 1.681 ± 0.005b 19.45 ± 0.05b 1.58 ± 0.0005b 0.765 ± 0.005b
VOME 100 mg/kg 14.0 ± 0.35b 12.16 ± 0.005b 0.685 ± 0.001b 15.55 ± 0.05b 1.38 ± 0.0005b 1.31 ± 0.005b
200 mg/kg 19.0 ± 0.05b 16.46 ± 0.005b 0.934 ± 0.001b 17.25 ± 0.05b 1.15 ± 0.005b 0.985 ± 0.005b
400 mg/kg 23.0 ± 0.45b 18.90 ± 0.001b 1.387 ± 0.005b 23.05 ± 0.05b 0.89 ± 0.0005b 0.435 ± 0.005b
Values are expressed as mean ± SEM. (n  10).
ap < 0.05 as compared to the control group.
bp < 0.05 vs. the disease group.
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FIGURE 7 | Effect of Viola odoratamethanolic extract on neurotransmitters. (A) Histogram indicating results of the serotonin level in the mice brain. (B) Histogram
indicating results of Noradrenaline level in the mice brain. (C)Histogram indicating results of dopamine level in themice brain. Data are expressed asmean ± SEM, n  10.
*P<0.05, **p < 0.01 and ***p < 0.001 as compared to the LPS-treated group. ###p < 0.001 as compared to the control group.
FIGURE 8 | Effect of Viola odorata methanolic extract on inflammatory biomarkers. (A) Histogram presenting results of TNF-α in the mice brain. (B) Histogram
presenting results of NFK-β in the mice brain. (C) Histogram presenting results of COX-2 in the mice brain. Data are expressed as mean ± SEM, n  10. ***p < 0.001 as
compared to the LPS-treated group. ###p < 0.001 as compared to the control group.
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